ProjectREMAP-CAP – Randomized, Embedded, Multifactorial, Adaptive Platform trial for Community-Acquired Pneumonia
Basic data
Acronym:
REMAP-CAP
Title:
Randomized, Embedded, Multifactorial, Adaptive Platform trial for Community-Acquired Pneumonia
Duration:
17/11/2020 to 31/12/2023
Abstract / short description:
The purpose of this study is to evaluate the effect of a series of interventions to improve outcomes in adult patients with severe community-acquired pneumonia (CAP) admitted to an intensive care unit.
Keywords:
community-acquired pneumonia
adaptive platform trial
Involved staff
Managers
Faculty of Medicine
University of Tübingen
University of Tübingen
Contact persons
Faculty of Medicine
University of Tübingen
University of Tübingen
Local organizational units
Internal Medicine Department I
Department of Internal Medicine
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Funders
Utrecht, Netherlands